BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11423572)

  • 21. Parathyroid-induced angiogenesis is VEGF-dependent.
    Carter WB; Uy K; Ward MD; Hoying JB
    Surgery; 2000 Sep; 128(3):458-64. PubMed ID: 10965318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
    Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
    Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis.
    Tufro-McReddie A; Norwood VF; Aylor KW; Botkin SJ; Carey RM; Gomez RA
    Dev Biol; 1997 Mar; 183(2):139-49. PubMed ID: 9126290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARB treatment prevents the decrease in endothelial progenitor cells and the loss of renal microvasculature in remnant kidney.
    Yu Y; Wang Y; Zhou LN; Zheng F
    Am J Nephrol; 2011; 33(6):550-7. PubMed ID: 21613782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction.
    Bige N; Shweke N; Benhassine S; Jouanneau C; Vandermeersch S; Dussaule JC; Chatziantoniou C; Ronco P; Boffa JJ
    Kidney Int; 2012 Jun; 81(12):1226-38. PubMed ID: 22418977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
    Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
    EXS; 1997; 79():233-69. PubMed ID: 9002222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects.
    Huang J; Kontos CD
    J Biol Chem; 2002 Mar; 277(13):10760-6. PubMed ID: 11784722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer.
    Reiher FK; Ivanovich M; Huang H; Smith ND; Bouck NP; Campbell SC
    J Urol; 2001 Jun; 165(6 Pt 1):2075-81. PubMed ID: 11371931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model.
    Kelly DJ; Hepper C; Wu LL; Cox AJ; Gilbert RE
    Nephrol Dial Transplant; 2003 Jul; 18(7):1286-92. PubMed ID: 12808163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.
    Nissen NN; Polverini PJ; Koch AE; Volin MV; Gamelli RL; DiPietro LA
    Am J Pathol; 1998 Jun; 152(6):1445-52. PubMed ID: 9626049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myofibroblast phenotypes expression in experimental renal scarring.
    Muchaneta-Kubara EC; el Nahas AM
    Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vascular endothelial growth factor in the regulation of angiogenesis.
    Ferrara N
    Kidney Int; 1999 Sep; 56(3):794-814. PubMed ID: 10469350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis.
    Cavallaro U; Tenan M; Castelli V; Perilli A; Maggiano N; Van Meir EG; Montesano R; Soria MR; Pepper MS
    J Cell Biochem; 2001; 82(4):619-33. PubMed ID: 11500940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor angiogenesis.
    Detmar M
    J Investig Dermatol Symp Proc; 2000 Dec; 5(1):20-3. PubMed ID: 11147670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.
    Vriese AS; Tilton RG; Elger M; Stephan CC; Kriz W; Lameire NH
    J Am Soc Nephrol; 2001 May; 12(5):993-1000. PubMed ID: 11316858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiological role of vascular endothelial growth factor in the remnant kidney.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Rasch R; Lameire NH; De Vriese AS
    Nephron Exp Nephrol; 2005; 101(1):e9-15. PubMed ID: 15925906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis and its regulation: roles of vascular endothelial cell growth factor.
    Nakagawa K; Chen YX; Ishibashi H; Yonemitsu Y; Murata T; Hata Y; Nakashima Y; Sueishi K
    Semin Thromb Hemost; 2000; 26(1):61-6. PubMed ID: 10805284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.